Mariska C. de Jong
About
In The Last Decade
Mariska C. de Jong
10 papers receiving 819 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 613
- Oncology 338
- Cancer Research 170
- Genetics 75
- Pediatrics, Perinatology and Child Health 60
Countries citing papers authored by Mariska C. de Jong
This map shows the geographic impact of Mariska C. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariska C. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariska C. de Jong more than expected).
Fields of papers citing papers by Mariska C. de Jong
This network shows the impact of papers produced by Mariska C. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariska C. de Jong. The network helps show where Mariska C. de Jong may publish in the future.
Co-authorship network of co-authors of Mariska C. de Jong
This figure shows the co-authorship network connecting the top 25 collaborators of Mariska C. de Jong. A scholar is included among the top collaborators of Mariska C. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariska C. de Jong. Mariska C. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 50 | |
| 3 | Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1. | 8 |
| 4 | 49 | |
| 5 | 13 | |
| 6 | Peptide transport by the multidrug resistance protein MRP1. | 49 |
| 7 | 72 | |
| 8 | Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. | 93 |
| 9 | 19 | |
| 10 | 440 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.